POS AM Filing

Talkspace, Inc. CIK: 1803901

Filing Information

Form Type	POS AM
Accession Number	`0001193125-22-070986`
Period End Date	20211231
Filing Date	20220310
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	d279692dposam_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 53 Cash Flow Statement 92 Stockholders Equity 32

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.46M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$198.26M	USD	Point-in-time
Accounts receivable, net of allowance of $4,918 and $824 as of December 31, 2021 and 2020, respectively	`AccountsReceivableNetCurrent`	$5.91M	USD	Point-in-time
Accounts receivable, net of allowance of $4,918 and $824 as of December 31, 2021 and 2020, respectively	`AccountsReceivableNetCurrent`	$5.51M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$9.56M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.51M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$213.33M	USD	Point-in-time
Allowance, Accounts Receivable	`AllowanceForDoubtfulAccountsReceivable`	-	USD	Point-in-time
Allowance, Accounts Receivable	`AllowanceForDoubtfulAccountsReceivable`	$4.92M	USD	Point-in-time
Allowance, Accounts Receivable	`AllowanceForDoubtfulAccountsReceivable`	$824.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.68M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$624.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$175.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deferred issuance cost	`DeferredCosts`	-	USD	Point-in-time
Deferred issuance cost	`DeferredCosts`	$692.00K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.20M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.44M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Goodwill	`Goodwill`	$6.13M	USD	Point-in-time
Goodwill	`Goodwill`	$6.13M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$82.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$32.87M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	129.40M	shares	Point-in-time
Total assets	`Assets`	$223.61M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.41M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	152.86M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.86M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.43M	USD	Point-in-time
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	2 Qtrs
Accounts payable	`AccountsPayableCurrent`	$7.90M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$5.17M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$7.19M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilitiesCurrent`	$12.56M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilitiesCurrent`	$7.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$20.49M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.18M	USD	Point-in-time
Warrant liabilities	`WarrantLiabilitiesNonCurrent`	$4.07M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$86.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$20.49M	USD	Point-in-time
Total liabilities	`Liabilities`	$31.33M	USD	Point-in-time
Commitments and contingencies (note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock (Series Seed, Seed-1, Seed-2, A, B, C and D) of $0.0001 par value Authorized: 0 and 95,709,146 shares at December 31, 2021 and 2020, respectively; Issued and outstanding: 0 and 94,582,550 shares at December 31, 2021 and 2020, respectively (1)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$111.28M	USD	Point-in-time
Convertible preferred stock (Series Seed, Seed-1, Seed-2, A, B, C and D) of $0.0001 par value Authorized: 0 and 95,709,146 shares at December 31, 2021 and 2020, respectively; Issued and outstanding: 0 and 94,582,550 shares at December 31, 2021 and 2020, respectively (1)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	-	USD	Point-in-time
Common stock of 0.0001 par value - Authorized: 1,000,000,000 and 129,397,278 shares at December 31, 2021 and 2020, respectively; Issued and outstanding: 152,862,447 and 13,413,431 shares at December 31, 2021 and 2020, respectively (1)	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock of 0.0001 par value - Authorized: 1,000,000,000 and 129,397,278 shares at December 31, 2021 and 2020, respectively; Issued and outstanding: 152,862,447 and 13,413,431 shares at December 31, 2021 and 2020, respectively (1)	`CommonStockValue`	$15.00K	USD	Point-in-time
Additional paid-in capital (1)	`AdditionalPaidInCapital`	$363.79M	USD	Point-in-time
Additional paid-in capital (1)	`AdditionalPaidInCapital`	$9.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-171.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-108.79M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-54.21M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$192.27M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$223.61M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$32.87M	USD	Point-in-time

Income Statement 53 line items

Line Item	Tag	Value	Unit	Period
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	Point-in-time
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$38.18M	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$113.67M	USD	Annual
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$76.19M	USD	Annual
Cost of revenues	`CostOfRevenue`	$18.04M	USD	Annual
Cost of revenues	`CostOfRevenue`	$46.90M	USD	Annual
Cost of revenues	`CostOfRevenue`	$26.35M	USD	Annual
Gross profit	`GrossProfit`	$66.77M	USD	Annual
Gross profit	`GrossProfit`	$49.84M	USD	Annual
Gross profit	`GrossProfit`	$20.14M	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$15.92M	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$9.58M	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$12.00M	USD	Annual
Clinical operations	`OtherCostAndExpenseOperating`	$4.33M	USD	Annual
Clinical operations	`OtherCostAndExpenseOperating`	$9.37M	USD	Annual
Clinical operations	`OtherCostAndExpenseOperating`	$4.67M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$47.70M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$100.64M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$27.54M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.36M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$34.77M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$10.20M	USD	Annual
Total operating expenses	`OperatingExpenses`	$49.56M	USD	Annual
Total operating expenses	`OperatingExpenses`	$160.69M	USD	Annual
Total operating expenses	`OperatingExpenses`	$71.82M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$93.92M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$21.98M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$29.43M	USD	Annual
Financial (income) expense, net	`InterestAndDebtExpenseIncome`	$-364.00K	USD	Annual
Financial (income) expense, net	`InterestAndDebtExpenseIncome`	$31.23M	USD	Annual
Financial (income) expense, net	`InterestAndDebtExpenseIncome`	$350.00K	USD	Annual
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$29.08M	USD	Annual
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$22.35M	USD	Annual
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$62.70M	USD	Annual
Taxes on income	`IncomeTaxExpenseBenefit`	$-8.00K	USD	Annual
Taxes on income	`IncomeTaxExpenseBenefit`	$-47.00K	USD	Annual
Taxes on income	`IncomeTaxExpenseBenefit`	$-24.00K	USD	Annual
Net loss	`NetIncomeLoss`	$62.74M	USD	Annual
Net loss	`NetIncomeLoss`	$22.37M	USD	Annual
Net loss	`NetIncomeLoss`	$29.09M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$22.37M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$62.74M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$29.09M	USD	Annual
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$0.72	USD	Annual
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$2.29	USD	Annual
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$1.67	USD	Annual
Weighted average number of common shares used in computing basic and diluted net loss per share (1)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.36M	shares	Annual
Weighted average number of common shares used in computing basic and diluted net loss per share (1)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	86.78M	shares	Annual
Weighted average number of common shares used in computing basic and diluted net loss per share (1)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.72M	shares	Annual

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$62.74M	USD	Annual
Net loss	`NetIncomeLoss`	$22.37M	USD	Annual
Net loss	`NetIncomeLoss`	$29.09M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$379.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.97M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$59.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$175.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Warrant issuance cost and change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	-	USD	Annual
Warrant issuance cost and change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	$31.78M	USD	Annual
Warrant issuance cost and change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	-	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$3.40M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$2.98M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$27.41M	USD	Annual
Decrease (increase) in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.02M	USD	Annual
Decrease (increase) in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-402.00K	USD	Annual
Decrease (increase) in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$840.00K	USD	Annual
Increase in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$8.05M	USD	Annual
Increase in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$216.00K	USD	Annual
Increase in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$695.00K	USD	Annual
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$503.00K	USD	Annual
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.56M	USD	Annual
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.28M	USD	Annual
Increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$-1.19M	USD	Annual
Increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$-2.03M	USD	Annual
Increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$-2.01M	USD	Annual
Increase in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$4.96M	USD	Annual
Increase in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.02M	USD	Annual
Increase in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$4.40M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.19M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-65.71M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.18M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$126.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$138.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$663.00K	USD	Annual
Acquisition of business	`PaymentsToAcquireBusinessesGross`	$10.69M	USD	Annual
Acquisition of business	`PaymentsToAcquireBusinessesGross`	-	USD	Annual
Acquisition of business	`PaymentsToAcquireBusinessesGross`	-	USD	Annual
Purchase of an intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Purchase of an intangible asset	`PaymentsToAcquireIntangibleAssets`	$939.00K	USD	Annual
Purchase of an intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Proceeds from restricted long-term bank deposit	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$447.00K	USD	Annual
Proceeds from restricted long-term bank deposit	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	-	USD	Annual
Proceeds from restricted long-term bank deposit	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-138.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-663.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.30M	USD	Annual
Proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	-	USD	Annual
Proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	-	USD	Annual
Proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	$249.33M	USD	Annual
Proceeds from issuance of convertible preferred stock, net	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$51.20M	USD	Annual
Proceeds from issuance of convertible preferred stock, net	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	Annual
Proceeds from issuance of convertible preferred stock, net	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	Annual
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	$6.00M	USD	Annual
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Repayment of borrowings	`RepaymentsOfDebt`	-	USD	Annual
Repayment of borrowings	`RepaymentsOfDebt`	$6.00M	USD	Annual
Repayment of borrowings	`RepaymentsOfDebt`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfStockIssuanceCosts`	$50.00K	USD	Annual
Payment of debt issuance costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.10M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$94.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$297.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$51.50M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$94.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$251.38M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-26.38M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$30.17M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$185.01M	USD	Annual
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$9.46M	USD	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalentsAtCarryingValue`	$198.26M	USD	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalentsAtCarryingValue`	$9.46M	USD	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalentsAtCarryingValue`	$198.26M	USD	Point-in-time
Cash paid during the year for interest	`InterestPaidNet`	$37.00K	USD	Annual
Cash paid during the year for interest	`InterestPaidNet`	$45.00K	USD	Annual
Cash paid during the year for interest	`InterestPaidNet`	$538.00K	USD	Annual
Employee taxes withheld related to restricted stock units vested	`EmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested`	$491.00K	USD	Annual
Employee taxes withheld related to restricted stock units vested	`EmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested`	-	USD	Annual
Employee taxes withheld related to restricted stock units vested	`EmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested`	-	USD	Annual
Deferred issuance cost on credit	`PaymentOfNoncashFinancingDeferredIssuanceCosts`	$692.00K	USD	Annual
Deferred issuance cost on credit	`PaymentOfNoncashFinancingDeferredIssuanceCosts`	-	USD	Annual
Deferred issuance cost on credit	`PaymentOfNoncashFinancingDeferredIssuanceCosts`	-	USD	Annual
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	$111.28M	USD	Annual
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	Annual
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	Annual

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	Point-in-time
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	2 Qtrs
Beginning balance	`StockholdersEquity`	$-54.21M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$192.27M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	152.86M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$297.00K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$94.00K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.10M	USD	Annual
Exercise of stock options, share	`StockIssuedDuringPeriodSharesStockOptionsExercised`	3.63M	shares	Annual
Restricted stock units settled	`RestrictedStockUnitsSettled`	$-491.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.40M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.98M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$27.41M	USD	Annual
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$125.00K	USD	Annual
Common stock issued related to exercise of warrants	`StockIssuedDuringPeriodValueWarrants`	$609.00K	USD	Annual
Acquisition of warrants	`StockIssuedDuringPeriodValueAcquisitions`	$27.95M	USD	Annual
Preferred stock conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$111.28M	USD	Annual
Issuance of common stock in connection with Business Combination and PIPE offering, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$184.94M	USD	Annual
Net loss	`NetIncomeLoss`	$62.74M	USD	Annual
Net loss	`NetIncomeLoss`	$22.37M	USD	Annual
Net loss	`NetIncomeLoss`	$29.09M	USD	Annual
Ending balance	`StockholdersEquity`	$-54.21M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$192.27M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	152.86M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.